Guangxi Liuzhou Pharm Co Ltd (603368) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.006x

Based on the latest financial reports, Guangxi Liuzhou Pharm Co Ltd (603368) has a cash flow conversion efficiency ratio of 0.006x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥45.64 Million ≈ $6.68 Million USD) by net assets (CN¥8.14 Billion ≈ $1.19 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Guangxi Liuzhou Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Guangxi Liuzhou Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 603368 current and long-term liabilities for a breakdown of total debt and financial obligations.

Guangxi Liuzhou Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guangxi Liuzhou Pharm Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
SmartStop Self Storage REIT, Inc. NYSE:SMA	0.041x
Guangdong Hongtu Technology Holdings Co Ltd SHE:002101	0.023x
Shenzhen Jiang and Associates Creative Design Co Ltd SHE:300668	0.019x
Equity Bancshares, Inc. NYSE:EQBK	0.012x
Vulcabras Azaleia S.A SA:VULC3	0.052x
Suning Universal Co Ltd SHE:000718	0.008x
Hbt Financial Inc NASDAQ:HBT	0.231x
Shanghai Hajime Advanced Material Technology Co. Ltd. SHE:301000	0.018x

Annual Cash Flow Conversion Efficiency for Guangxi Liuzhou Pharm Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Guangxi Liuzhou Pharm Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see 603368 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥7.94 Billion ≈ $1.16 Billion	CN¥838.51 Million ≈ $122.70 Million	0.106x	+25.55%
2023-12-31	CN¥7.06 Billion ≈ $1.03 Billion	CN¥594.41 Million ≈ $86.98 Million	0.084x	+5.77%
2022-12-31	CN¥6.37 Billion ≈ $931.45 Million	CN¥506.43 Million ≈ $74.11 Million	0.080x	+38.77%
2021-12-31	CN¥5.81 Billion ≈ $849.64 Million	CN¥332.88 Million ≈ $48.71 Million	0.057x	-53.04%
2020-12-31	CN¥5.44 Billion ≈ $796.71 Million	CN¥664.69 Million ≈ $97.26 Million	0.122x	+37.70%
2019-12-31	CN¥4.66 Billion ≈ $681.54 Million	CN¥412.91 Million ≈ $60.42 Million	0.089x	+1508.91%
2018-12-31	CN¥4.05 Billion ≈ $592.21 Million	CN¥22.30 Million ≈ $3.26 Million	0.006x	+105.91%
2017-12-31	CN¥3.57 Billion ≈ $522.19 Million	CN¥-332.59 Million ≈ $-48.67 Million	-0.093x	-378.42%
2016-12-31	CN¥3.24 Billion ≈ $473.78 Million	CN¥108.39 Million ≈ $15.86 Million	0.033x	+142.47%
2015-12-31	CN¥1.36 Billion ≈ $199.10 Million	CN¥-107.25 Million ≈ $-15.69 Million	-0.079x	+30.12%
2014-12-31	CN¥1.17 Billion ≈ $171.78 Million	CN¥-132.42 Million ≈ $-19.38 Million	-0.113x	-353.08%
2013-12-31	CN¥501.00 Million ≈ $73.31 Million	CN¥22.33 Million ≈ $3.27 Million	0.045x	-72.11%
2012-12-31	CN¥378.59 Million ≈ $55.40 Million	CN¥60.51 Million ≈ $8.85 Million	0.160x	-67.14%
2011-12-31	CN¥274.23 Million ≈ $40.13 Million	CN¥133.38 Million ≈ $19.52 Million	0.486x	--

About Guangxi Liuzhou Pharm Co Ltd

SHG:603368 China Medical Distribution

Market Cap

$973.00 Million

CN¥6.65 Billion CNY

Market Cap Rank

#9226 Global

#2489 in China

Share Price

CN¥16.74

Change (1 day)

-1.41%

52-Week Range

CN¥16.23 - CN¥20.31

All Time High

CN¥62.90